%0 DATA
%A Kim, A. Nguyen
%A Nasheeta, Peer
%A Edward, J. Mills
%A Andre, P. Kengne
%D 2016
%T Overall metabolic syndrome prevalence in the HIV-infected: Adult Treatment Panel III (ATPIII) 2001 criteria.
%U https://plos.figshare.com/articles/Overall_metabolic_syndrome_prevalence_in_the_HIV_infected_Adult_Treatment_Panel_III_ATPIII_2001_criteria_/3134863
%R 10.1371/journal.pone.0150970.g002
%2 https://plos.figshare.com/ndownloader/files/4875577
%K EGIR
%K ATPIII
%K JIS
%K NNRTI
%K Metabolic Syndrome Prevalence
%K age 41 years
%K MS prevalence
%K IDF
%K publication
%K criteria
%K CI
%K infection
%K participant
%K severity
%K HIV
%X For each study the black box represents the study estimate (prevalence of metabolic syndrome [MS]) and the horizontal bar about the 95% confidence intervals (95%CI). The size of the boxes is proportional to the inverse variance. The diamond at the lower tail of the figure is for the pooled effect estimates from random effects models. The proportional contribution of each study (weight) to the pooled estimates is also shown, together with the prevalence estimates and measures of heterogeneity. The dotted vertical line is centred on the pooled estimates.